Daniel Janney sold $16.0M of Krystal Biotech (KRYS)

Executed Feb 24, disclosed Feb 26, 2 days later.

Value, as filed

$16.0M

59,729 sh across 18 lots

Executed

Feb 24

the trade date, as filed

Disclosed

Feb 26

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel Janney Director profile →

Daniel Janney (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $16.0M of KRYS (59,729 sh across 18 lots, as filed), executed Feb 24.

The name

KRYS

Krystal Biotech, Inc. KRYS · Healthcare · 25 filings in 24 months ticker →

Healthcare · Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Janney in KRYS

KRYSSALE Krystal Biotech, Inc. $3.3M
11,803 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET